Gossamer Bio GOSS Cash Flow Statement (2018-2026)

NASDAQ GOSS
$9.79 +0.21 (+2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Gossamer Bio Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Gossamer Bio reported cash from operations of -$39.42M and free cash flow of -$39.42M for the quarter ended Jun 2026, up 16.2% year over year. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-60.25M-56.28M-57.79M-56.47M-59.36M-55.76M-49.17M-42.50M-40.01M-48.15M-41.93M49.23M-30.80M-33.03M-36.64M-38.27M-48.22M-47.24M-46.66M16.90M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.70M1.75M0.29M0.30M0.30M0.27M0.35M0.34M0.32M0.31M0.29M0.32M0.23M0.24M0.24M0.25M0.25M0.25M0.26M4.96M
Depreciation & Amortization (CF)Dep. & Amort.
0.50M0.44M0.50M0.50M0.50M0.43M0.50M0.50M0.40M0.29M0.26M0.30M0.20M0.11M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp.
7.59M7.66M10.98M10.00M10.12M11.45M8.13M8.20M6.16M6.03M5.81M5.00M4.84M4.97M2.41M2.59M2.67M2.90M6.30M2.46M
Gains from Sales and DivestituresGains Divest
0.06M-0.73M-0.32M-0.31M-0.19M
Gains from Investment SecuritiesGains Investment
4.11M
Other non-cash itemsOther Non-Cash
0.88M0.77M0.67M0.65M0.67M0.61M0.69M0.70M0.67M0.71M0.73M0.74M0.88M0.97M0.34M7.69M-7.26M0.23M-45.45M
Change in Working Capital
Change in ReceivablesChange Receivables
3.63M2.96M-1.25M1.25M1.00M1.66M2.98M-2.98M-3.15M
Change in Account PayablesChange Payables
-0.18M2.38M-2.51M3.71M-3.30M0.29M1.22M-0.51M-0.99M4.26M-2.92M-1.52M-0.30M3.08M-0.94M-5.84M-0.80M4.82M6.16M-4.59M
Change in Accured ExpensesChange Accured Exp.
8.97M-3.98M-5.80M2.62M5.67M-4.14M-8.12M2.78M0.85M1.24M-9.27M2.99M-3.50M-0.94M-5.84M3.01M5.33M-1.05M2.50M-4.65M
Change in Other Operating AssetsOther Assets Change
-2.55M-1.44M2.53M1.67M-3.50M-1.40M2.42M2.72M1.23M-2.54M0.78M1.36M-1.92M-0.61M0.95M4.52M-0.86M3.96M-2.43M-6.44M
Change in Other Operating LiabilitiesOther Liabilities Change
1.53M3.27M1.44M-2.02M7.16M-4.43M-3.38M1.28M0.68M-3.45M1.95M69.45M-2.44M-6.98M3.25M1.47M-1.57M2.69M-12.99M-10.89M
Other Working Capital ChangesOther WC Changes
4.08M4.72M-1.09M-3.69M10.65M-3.03M-5.80M-1.44M-0.55M-0.91M1.18M68.09M-0.53M-6.36M2.30M-3.04M-0.72M-1.28M-10.57M-4.44M
Cash from OperationsCash from Ops.
-42.04M-40.51M-53.48M-48.82M-37.00M-47.73M-52.99M-38.25M-34.49M-33.42M-52.30M116.35M-32.03M-35.48M-39.72M-47.06M-36.17M-48.31M-38.72M-39.42M
Investing Activities
Capital ExpendituresCapex
0.52M0.08M0.16M0.12M0.03M0.10M0.03M0.05M
Change in Property, Plant and EquipmentChange in PP&E
-0.52M-0.08M-0.16M-0.12M-0.03M-0.10M-0.03M-0.05M
Change in IntangiblesChange Intangibless
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.03M
Purchase of InvestmentsInvestments Purchased
93.97M8.13M37.40M35.19M88.05M77.42M76.86M56.45M188.09M120.27M86.13M193.61M131.35M83.68M101.01M75.52M29.59M20.99M24.99M
Sale and Maturity of InvestmentsInvestments Sold
4.75M18.68M46.00M40.00M65.50M86.00M85.60M69.40M69.80M105.90M147.80M134.50M104.60M136.90M123.10M119.70M46.60M94.14M66.60M42.70M
Cash from Investing ActivitiesCash from Investing
-89.76M10.44M8.42M4.68M-22.60M8.46M8.72M12.94M-118.26M-14.37M61.67M-59.11M-26.75M53.22M22.06M44.13M17.01M73.16M41.61M42.70M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
2.90M2.90M2.90M2.90M2.90M2.90M2.90M9.68M
Non-Current Debt
-2.90M-2.90M-2.90M-2.90M-2.90M-2.90M-2.90M-9.68M
Net Debt Issuances and RepaymentsNet Debt Issuance
-2.90M-2.90M-2.90M-2.90M-2.90M-2.90M-2.90M-9.68M
Change in Capital Stock
Common Stock IssuedStock Issued
1.91M0.37M0.72M0.02M122.12M0.03M0.37M201.40M0.35M0.28M0.46M0.50M0.09M1.87M3.96M0.51M
Net Shares Issued and RepurchasedNet Shares Issued
1.91M0.37M0.72M0.02M122.12M0.03M0.37M201.40M0.35M0.28M0.46M0.50M0.09M1.87M3.96M0.51M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
1.91M0.37M0.72M0.02M122.12M0.03M0.37M201.40M0.35M0.28M0.46M0.50M0.09M1.87M3.96M0.51M
Cash from Financing ActivitiesCash from Financing
1.91M0.37M0.72M0.02M119.22M-2.87M-2.54M-2.90M198.50M-2.90M-2.56M-9.21M0.28M0.50M0.09M1.87M3.96M0.51M-3.14M
Additional items
Exchange Rate EffectFX Effect
0.40M-0.38M-0.15M-0.53M-0.47M0.64M0.07M-0.02M-0.14M0.19M-0.06M-0.01M0.09M-0.13M0.11M0.13M-0.10M0.00M-0.10M-0.01M
Change in Cash
-129.48M-30.07M-44.50M-44.66M59.16M-41.50M-46.73M-28.24M45.61M-50.50M6.75M48.01M-58.41M17.61M-17.05M-2.71M-17.38M28.80M3.30M0.12M
Ending Cash Balance
213.54M183.47M138.97M94.32M153.48M111.97M65.24M37.00M82.61M32.11M38.86M86.88M28.46M46.07M29.02M26.31M8.93M37.73M41.03M41.15M
Free Cash FlowFCF
-42.56M-40.59M-53.64M-48.94M-37.03M-47.83M-52.99M-38.25M-34.49M-33.42M-52.30M116.35M-32.03M-35.48M-39.75M-47.11M-36.17M-48.31M-38.72M-39.42M
Net Cash FlowNCF
-129.88M-29.70M-44.34M-44.12M59.63M-42.14M-46.80M-28.22M45.74M-50.69M6.82M48.02M-58.51M17.74M-17.16M-2.84M-17.28M28.80M3.40M0.13M
Interest Paid
0.69M5.68M0.68M5.69M0.68M5.67M0.66M5.62M0.55M5.46M0.37M5.19M5.00M5.00M5.00M5.08M

Gossamer Bio Cash Flow Statement API

Pull Gossamer Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GOSS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY